Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 30, 1995 - Issue sup212
Submit an article Journal homepage
10
Views
5
CrossRef citations to date
0
Altmetric
Original Article

NSAID-associated Upper Gastrointestinal Damage in Patients with Rheumatoid Arthritis

B. A. C. Dijkmans Depts. of Rheumatology, Clinical Epidemiology and Gastroenterology, University Hospital, Leiden, The Netherlands
,
M. Janssen Depts. of Rheumatology, Clinical Epidemiology and Gastroenterology, University Hospital, Leiden, The Netherlands
,
J. P. Vandenbroucke Depts. of Rheumatology, Clinical Epidemiology and Gastroenterology, University Hospital, Leiden, The Netherlands
&
C. B. H. W. Lamers Depts. of Rheumatology, Clinical Epidemiology and Gastroenterology, University Hospital, Leiden, The Netherlands
Pages 105-108 | Published online: 08 Jul 2009

References

  • Semble E L, Wu W C, Gastell D O. Nonsteroidal anti-inflammatory drugs and oesophageal injury. Semin Arthritis Rheum 1989; 19: 99–109
  • Piper D W, McIntosh J H, Ariotti D E, Fenton B H, McLennan R. Analgesic ingestion and chronic peptic ulcer. Gastroenterology 1981; 80: 427–32
  • Collier D SU, Pain J A. Nonsteroidal anti-inflammatory drugs and peptic ulcer. Gut 1985; 26: 359–63
  • Sun D CH, Roth S M, Mitchell C S, England D W. Upper gastrointestinal disease in rheumatoid arthritis. Dig Dis Sci 1974; 19: 405–10
  • Silvoso G R, Ivey J J, Butt J H, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91: 517–20
  • Janssen M, Dijkmans B AC, Lamers C BHW. Upper gastrointestinal manifestations in rheumatoid arthritis patients: intrinsic or extrinsic pathogenesis?. Scand J Gastroenterol 1990; 25(Suppl 178)79–84
  • Armstrong C D, Blower A L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987; 28: 527–32
  • Janssen M, Dijkmans B AC, van der Sluys F A, et al. Upper gastrointestinal complaints and complications in chronic rhe umatic patients in comparison with other chronic diseases. Br J Rheumatol 1992; 31: 747–52
  • Janssen M, Dijkmans B AC, Vandenbroucke J P, Biemond I, van Duyn W, Zwinderman A H, et al. Serum values of pepsinogens and antibodies to Helicobacter pylori in relation to a history of peptic ulcer disease and NSAID use. Scand J Rheumatol
  • Janssen M, Dijkmans B AC, Vandenbroucke J P, Biemond I, Lamers C BHW. The frequency of extremely low serum pepsinogen, indicative of corpus gastritis with severe atrophy, in rheumatoid arthritis, other chronic rheumatic diseases and non-rheumatis disorders. Br J Rheumatol 1993; 32: 371–4
  • Janssen M, Dijkmans B AC, Vandenbroucke J P, Biemond I, Lamers C BHW. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use. Dig Dis Sci 1994; 39: 362–5
  • Braga L L, Sarasiek J, Marshall B, McCallum R W, Barrett L, Guerrant R. Gold—a new potential drug treatment of Helicobacter pylori infection. Gastroenterology 1990; 98, (abstract)
  • Taha A S, Sturrock R D. The gold plated stomach?. Ann Rheum Dis 1993; 52: 89–90
  • Janssen M, Dijkmans B AC, Vandenbroucke J P, van Duyn W, Pena A S, Lamers C BHW. Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold. Ann Rheum Dis 1992; 51: 1036–8
  • Woldeten S, Janssen M, van Duyn W, Lamers C BHW, Hermans J, Dijkmans B AC. No effect of intramuscular gold therapy on serologic parameters of Helicobacter pylori infection in patients with rheumatoid arthritis; a 12-month prospective study. Ann Rheum Dis 1994; 53: 400–2
  • Janssen M, Dijkmans B AC, Lamers C BHW, Zwinderman A L, Vandenbroucke J P. A gastroscopic study of the predictive value of risk factors for non-steroidal anti-inflammatory drug-associated ulcer disease in rheumatoid arthritis patients. Br J Rheumatol 1994; 33: 449–54
  • Janssen M, Baak L C, Janssen J BMJ, Dijkmans B AC, Vandenbroucke J P, Lamers C BHW. Effects of indomethacin on intragastric pH and meal-stimulated serum gastrin secretion in rheumatoid arthritis patients. Aliment Pharmacol Ther 1993; 7: 393–400

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.